Psychopharmacology Super-Bundle 7-Part Series + 5 Applications Workshops

Training Library

Psychopharmacology Super-Bundle 7-Part Series + 5 Applications Workshops

$499.00
1 license × $499.00 = $499.00

Buying for an organization? Submit a purchase order. Access starts after payment is received.

BCBA CEUs- 19 BACB Learning CEUs for BCBAs/BCaBAs

Providers of Healthcare or education serving the needs of individuals with Autism or other special needs encounter medication-related issues on a daily basis. Virtually every professional (and parent) understands that medication plays a significant factor in a person’s ability to function and make progress, but very few possess sufficient levels of knowledge to make informed decisions when providing services to children, adolescents, and adults receiving medication. This lack of knowledge is even more pronounced when dealing with co-morbid conditions. 

SL Global’s Psychopharmacology series, with Dr. Ronald T. Brown and Dr. Debbie Coehlo, is designed to provide educators, healthcare providers, and parents with a comprehensive understanding of psychopharmacology and its impact on various childhood disorders.  Each 2-hour session will be broken down into three primary areas: (1) study on classes of medication; (2) how it relates to various symptoms; and (3) use of case studies to provide a deeper level of understanding by seeing how both come together in practice. 

This series includes the following titles:

MANDATORY DISCLAIMER: The Behavior Analyst Certification Board  (“BACB”) does not sponsor, approve or endorse Special Learning, the materials, information, or sessions identified herein.

For cancellations and refunds, please see our policy HERE.

Learning objectives

Psychopharmacology Webinar Series Module 1: Overview of Psychopharmacology and Childhood Disorders
  • Compare the different categories of medications used to treat common mental health disorders in childhood.
  • Explain the difference between treating internalizing behaviors versus externalizing behaviors.
  • Describe the steps taken by healthcare providers when deciding on which medications to use with a specific child.
  • Explain important factors to monitor when a child is on medication(s).
  • Discuss the importance of holistic care, including healthy lifestyle changes, healthy sleep patterns, behavior management counseling, parenting counseling, educational consultation, and the use of supplements in addition to medications when treating childhood disorders.
  • List common myths associated with the use of medications in the treatment of childhood disorders.
  • Explain the use of off-label medications in children and the FDA medication approval process.
  • Apply knowledge to case studies of children with childhood disorders treated with medications.
Psychopharmacology Webinar Series Module 2: Psychopharmacology and ADHD
  • Recognize specific target behaviors associated with ADHD for which psychopharmacology is effective.
  • Identify classes of psychotropic agents which have demonstrated effectiveness in the treatment of ADHD
  • Understand common medications used in the treatment of ADHD, including the indication, mechanism of action, adverse and side effects, and monitoring criteria
  • Explore and discuss the most effective behavior strategies that are seen throughout various developmental stages of treatment for ADHD.
  • Apply knowledge to specific case studies including assessment, diagnosis, treatment, and evaluation of outcomes.
  • Identify skills required to approach parents about the potential benefits of psychotropic medication for their children.
Psychopharmacology and Autism: [Clinical Applications Workshop]
  • Data collection procedures that can be implemented prior to starting a medication program;
  • Ongoing data collection procedures to analyze the effectiveness of medication;
  • Strategies to share data with other members of the treatment team to ensure alignment between stakeholders to maximize outcomes.
Psychopharmacology Webinar Series Module 3: Psychopharmacology and Autism
  • Recognize specific target behaviors associated with the diagnosis of ASD.
  • Explore and discuss the most effective and evidence-based behavior strategies that are seen throughout various developmental stages of treatment for ASD.
  • Evaluate environmental factors that may interfere with positive function in a child with ASD.
  • Discuss the importance of a team approach to the care of a child with ASD across different developmental stages.
  • Identify classes of psychotropic agents which have demonstrated effectiveness in the treatment of ASD.
  • Discuss common medications used in the treatment of ASD, including the indication, mechanism of action, adverse and side effects, and monitoring criteria.
  • Apply knowledge to specific case studies including assessment, diagnosis, treatment, and evaluation of outcomes.
  • Identify skills required to approach parents about the potential benefits of psychotropic medication for their children.
  • Analyze ethical issues arising during the treatment of a child with ASD and their families.
Psychopharmacology and Mood Disorders: [Clinical Applications Workshop]
  • Data collection procedures that can be implemented prior to starting a medication program;
  • Ongoing data collection procedures to analyze the effectiveness of medication;
  • Strategies to share data with other members of the treatment team to ensure alignment between stakeholders to maximize outcomes.
Psychopharmacology Webinar Series Module 5: Psychopharmacology and Evidence-Based Practices
  • Review the reasons for more children being prescribed psychotropic medications in the US, including increased diagnosis of treatable conditions, increased access to safe medications, and increased trauma-related disorders in children.
  • Explore and discuss the most effective and evidence-based strategies to treat mental health disorders in children that are seen throughout various developmental stages.
  • Evaluate societal and cultural factors that may influence whether medications are used to treat mental health disorders in children.
  • Identify classes of psychotropic agents which have demonstrated effectiveness in the treatment of mental health disorders in children.
  • Discuss common medications used in the treatment of mental health disorders in children including the indication, mechanism of action, adverse and side effects, and monitoring criteria.
  • Apply knowledge to specific case studies including assessment, diagnosis, treatment, and evaluation of outcomes.
  • Analyze ethical issues arising when using medications to treat mental health disorders in children.
  • Examine approaches used to discussing medications with parents of children with mental health disorders.
Psychopharmacology and Evidence-Based Practices [Clinical Applications Workshop]
  • Data collection procedures that can be implemented prior to starting a medication program;
  • Ongoing data collection procedures to analyze the effectiveness of medication;
  • Strategies to share data with other members of the treatment team to ensure alignment between stakeholders to maximize outcomes.
Psychopharmacology Webinar Series Module 6: Ethics of Medication
  • Review the reasons for more children being prescribed psychotropic medications in the US, including increased diagnosis of treatable conditions, increased access to safe medications, and increased trauma-related disorders in children.
  • Explore and discuss the four ethical principles and how they apply to prescribe psychotropic medications in children.
  • Evaluate societal and cultural factors that may influence whether medications are used to treat mental health disorders in children.
  • Analyze concerns regarding the use of psychotropic medications in children, including over-prescribing, failure to consider behavioral approaches when indicated, polypharmacy, and inappropriate use of “off-label” medications.
  • Apply knowledge to specific case studies including assessment, diagnosis, treatment, and evaluation of outcomes.
  • Examine approaches used to discuss ethical principles related to prescribing medications with parents of children with mental health disorders.
Psychopharmacology: Ethics of Medication [Clinical Applications Workshop]
  • Explain the four ethical principles and how they apply to prescribe psychotropic medications in children.
  • Evaluate societal and cultural factors that may influence whether medications are used to treat mental health disorders in children.
  • Apply knowledge to specific case studies including assessment, diagnosis, treatment, and evaluation of outcomes.
  • Examine approaches used to discussing ethical principles related to prescribing medications with parents of children with mental health disorders.
Psychopharmacology Webinar Series Module 7: Psychopharmacology: Diagnosis and Assessment
  • Recognize specific target behaviors associated with the diagnosis of the different mental health diagnoses in childhood.
  • Explore and discuss symptoms of mental health disorders that are seen throughout various developmental stages of childhood.
  • Evaluate environmental factors that may impact a child’s functional ability.
  • Review common screening and assessment tools used to assess and monitor mental health diagnoses in children.
  • Review the DSM-5 diagnostic criteria used to diagnose common mental health disorders in children.
  • Identify classes of psychotropic medications that have demonstrated effectiveness in the treatment of mental health in childhood.
  • Discuss the benefits versus the risks of accurate assessment and diagnoses and treatment outcomes when treating children with mental health disorders.
  • Apply knowledge to specific case studies including assessment, diagnosis, treatment, and evaluation of outcomes.
  • Analyze ethical issues arising during the assessment and diagnosis of a child with mental health diagnoses.
Psychopharmacology: Diagnosis and Assessment [Clinical Applications Workshop]
  • Data collection procedures that can be implemented prior to starting a medication program;
  • Ongoing data collection procedures to analyze the effectiveness of medication;
  • Strategies to share data with other members of the treatment team to ensure alignment between stakeholders to maximize outcomes.

Keep browsing · Cart

You may also like